SciELO - Scientific Electronic Library Online

 
vol.14 issue4Labor differences between people with congenital and adulthood acquired disability. Secondary analysis of the National Disability Survey - ENEDIS 2012Factors associated with a positive cytological result in Papanicolau tests in women attended In the Peruvian league against author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

  • Have no cited articlesCited by SciELO

Related links

  • Have no similar articlesSimilars in SciELO

Share


Revista del Cuerpo Médico Hospital Nacional Almanzor Aguinaga Asenjo

Print version ISSN 2225-5109On-line version ISSN 2227-4731

Rev. Cuerpo Med. HNAAA vol.14 no.4 Chiclayo Oct./Dec. 2021  Epub Dec 29, 2021

http://dx.doi.org/10.35434/rcmhnaaa.2021.144.1451 

Original Article

Perceptions of self-medication of the population, during the covid-19 pandemic in Peru

Percepciones de automedicación de la población durante la pandemia covid-19 en Perú

Luis Alberto Inostroza-Ruiz1  , Químico Farmacéutico
http://orcid.org/0000-0002-8038-0730

Paul Ivan Gutiérrez-Elescano1  , Químico Farmacéutico
http://orcid.org/0000-0003-3426-5915

Nelson Bautista-Cruz1  , Químico Farmacéutico
http://orcid.org/0000-0003-0932-2332

Jose Alfonso Apesteguia-Infantes1  , Químico Farmacéutico
http://orcid.org/0000-0001-6546-2298

José Fidel Jáuregui-Maldonado1  , Químico Farmacéutico
http://orcid.org/0000-0003-1796-2030

Edgar Robert Tapia-Manrique1  , Químico Farmacéutico
http://orcid.org/0000-0002-6270-9838

Dulce E. Alarcón-Yaquetto2  , Bióloga, Magister en Informática Biomédica en Salud Global
http://orcid.org/0000-0003-0300-4683

Agueda Muñoz del Carpio-Toia3  4  , Médico Cirujano, Magister en Salud Pública, Doctora en Medicina
http://orcid.org/0000-0003-0501-7314

1 Facultad de Farmacia y Bioquímica, Universidad Nacional Mayor de San Marcos, Lima, Perú.

2 Unidad de Conocimiento y Evidencia, Universidad Peruana Cayetano Heredia, Lima, Perú.

3 Vicerrectorado de Investigación, Universidad Católica de Santa María, Arequipa, Perú.

4 Escuela de Postgrado, Universidad Católica de Santa María, Arequipa, Perú.

ABSTRACT

OBJECTIVE:

Describe characteristics of self-medication of the population, in the context of the COVID 19 pandemic.

METHODS:

We carried out a cross-sectional survey with students in a major public Peruvian university. We measured perception of self-medication of the population, as well as characteristics, consequences, and associated factors.

RESULTS:

A total of 274 students of Pharmacy and biochemistry filled in the questionnaire, 80.3% of which reported to know someone that self-medicated during the COVID-19 pandemic. 98.9 % of surveyed participants considered that the current pandemic increased self-medication practices in the population and that it occurred more frequently when people have symptoms associated with COVID-19 (65.4%). The medicines most frequently used were ivermectin (79.2%), azithromycin (71.2%) and hydroxychloroquine (38.7%).

CONCLUSION:

According to the surveyed participants, self-medication has increased in the general population during the COVID-19 pandemic. Strategies to prevent these practices are needed, as they could delay adequate medical care.

Key words: COVID-19; Students; Self-medication; Population

RESUMEN

OBJETIVO:

Describir las características de la automedicación de la población, en el contexto de la pandemia de COVID 19.

MÉTODOS:

Realizamos una encuesta transversal con estudiantes de una importante universidad pública peruana. Se midió la percepción de la automedicación de la población, así como características, consecuencias y factores asociados.

RESULTADOS:

Completaron el cuestionario un total de 274 estudiantes de Farmacia y Bioquímica, de los cuales el 80,3% refirió conocer a alguien que se automedicó durante la pandemia de COVID-19. El 98,9% de los encuestados consideró que la pandemia actual aumentó las prácticas de automedicación en la población y que se presentó con mayor frecuencia cuando las personas presentan síntomas asociados al COVID-19 (65,4%). Los medicamentos más utilizados fueron ivermectina (79,2%), azitromicina (71,2%) e hidroxicloroquina (38,7%).

CONCLUSIÓN:

Según los participantes encuestados, la automedicación ha aumentado en la población general durante la pandemia de COVID-19. Se necesitan estrategias para prevenir estas prácticas, ya que podrían retrasar la atención médica adecuada.

Palabras clave: COVID-19; Estudiantes; Automedicación; Población

INTRODUCTION

Self-medication -defined as the consumption of a product for preventing or treating an illness or disease without a doctor's prescription- is a common practice with widely documented adverse effects1,2. Self-medication is a relevant problem in Latin America and low- and middle-income countries, where a poorly regulated pharmaceutical market has been described3,4. Because of its adverse effects, it is a major public health concern, as it exposes the population to increased drug resistance, serious side effects or delayed medical attention5.

Due to the new coronavirus disease (COVID-19), self-medication has increased6 in the face of excessive hospital demand which health systems have been unable to cope with7,8. Given the lack of responsiveness, a high prevalence of self-medication has been reported, especially in people at higher risk of infection9-12. Absence of a pharmacological treatment for the disease or fear about becoming seriously ill12) have been suggested as the main reasons for self-medication.

In a context where health systems are at their maximum capacity, the work of pharmacists is essential, as they represent the most accessible and sometimes the first link between the patient and the health system13. In Peru, their functions are regulated by the General Health Law, which establishes that they are responsible for "dispensing, information and guidance to the user on the administration, use and dosage of the pharmaceutical product"14. Within Pharmacy training, emphasis is placed on their role as a link between the general population and the health system, being fundamental in times of health crisis, ensuring optimal pharmacological management and communication strategies to avoid self-medication15.

University pharmacy students in their final year are already exposed to pre-professional internships, in health services pharmacies, where they have first-hand experience with the population and with self-medication practices increased even further under the uncertainty of the pandemic; therefore, they could give an idea of ​​the real dimension of the problem of self-medication during the COVID-19 pandemic.

For these reasons, the present study sought to describe the perceptions of students and faculty of a Pharmacy School of a Peruvian public university on the self-medication of the population in the context of the COVID-19 pandemic. These results will serve as a basis for defining strategies to address the problem, with an emphasis on the populations that are perceived to be most predisposed to self-medication.

MATERIAL AND METHODS

Design and setting

The present study is an exploratory, cross-sectional research. The sampling was non-probabilistic. Students in the final year of the Pharmacy and Biochemistry course at a major public Peruvian university were recruited.

Data collection

For data collection, the research team developed a questionnaire made up of questions related to socio-demographic variables, characteristics of self-medication of the population and factors associated with self-medication in the COVID-19 pandemic. Seven experts participated in its validation. Each item was analyzed in terms of content validity, i.e. whether the questions were needed to understand perceptions about the phenomenon of self-medication, applicability, and feasibility (clear wording and coherence). The questionnaire was distributed a total of students in the final year of the Pharmacy and Biochemistry course at a major public Peruvian university.

Data analysis

To analyze data, the research team measured socio-demographic variables, characteristics of self-medication and associated factors in the context of the COVID-19 pandemic. The study described categorical variables using absolute and relative frequencies; quantitative variables were expressed as mean and standard deviation. Statistical analysis and graphs were performed with the open-source software RStudio v. 1.3.1073.

Ethics

The study was approved by the institutional ethics of research Committee of the Universidad Católica de Santa María (UCSM) with favorable dictum number 185 - 2020. All participants had to consent to participate through a virtual informed consent form prior accessing the questionnaire.

RESULTS

A total of 360 students were invited to participate of which 274 responded and were included in the study (76.1%). 55.8% were women and the mean age was 23.3 ± 4.5 (See table 1). Of the total number of respondents, 80.3% reported having knowledge of someone who self-medicated during the COVID-19 pandemic. Figure 1A presents these results differentiated by the person who self-medicated. Respondents reported that their family members (52.3%) and friends (40.1%) most frequently self-medicated during the pandemic.

Table 1 Characteristics of the studied sample 

Characteristic Total (n=274) Yes (n=220) No (n=54) p value
Age 23.27± 4.5 23 (21-24) 22 (20-24) 0.144
< 25 212 (77.4) 168 (76.4) 44 (81.5) 0.717
25 - 39 58 (21.2) 48 (21.8) 10 (18.5)
> 40 4 (1.5) 4 (1.8) 0
Sex
Male 119 (43.4) 91 (41.4) 28 (51.9) 0.316
Female 153 (55.8) 127 (57.7) 26 (48.2)
Other 2 (0.7) 2 (0.91) 0

Participants were grouped according to whether or not they perceived self-medication increased during the pandemic. Values are mean ± SD or frequency and percentage n (%).

Pharmacies (79.2%) and apothecaries or drugstores (76.3%) are the most frequent places where medicines are obtained (Figure 1B). The most common perceived reason for self-medication was the occurrence of a COVID-19 symptom (Figure 1C). while the pharmacy technician (53.3%), a family member (47.1%) or acquaintance who has had COVID-19 (48.9%) are the most frequent persons who indicate the medicine (Figure 1 D).

Figure 1 Legends of figures. Pharmacy students’ perceived reasons regarding who self-medicates the most (A), the person recommending the medicines (B), reasons for self-medication and places where people buy medicines (D) in the context of the COVID-19 pandemic. SM: Self-medication, MINSA: Peruvian Minister of Health. 

The main symptoms for which a person self-medicates are sore throat (68.3%), cough (61.1%) and general malaise (46.7%). 96.4% consider that COVID-19 increased self-medication. The main causes identified by respondents are lack of treatment (47.2%), lack of vaccine availability (48.7%) and the belief that there are no effects associated with self-medication (59.9%). No respondent considered lack of awareness of self-medication as a reason for the phenomenon.

Ivermectin (79.2%), azithromycin (71.2%), paracetamol (69.3%) and dexamethasone (62.4%) are considered the most consumed drugs in the pandemic by COVID-19. To a lesser extent, hydroxychloroquine (38.7%), vitamins and minerals (32.5%), chlorine dioxide (31.3%) and warfarin (22.9%). The most frequent adverse effects were vomiting (58.3%), diarrhea (46.4%), renal (33.2%), respiratory (30.6%) and hepatic (30.1%) failures. Perceptions of the students on the effects of self-medication on the treatment of COVID-19 are also presented (see table 2).

Table 2 Perceptions of the adverse effects of self-medication and consequences of medication on COVID-19 treatment 

Adverse effect Yes No % Yes
Nausea/Vomiting 114 160 58.39
Diarrhea 127 147 46.35
Renal failure 91 183 33.21
Acute hepatic failure 82 191 30.04
Respiratory failure 84 190 30.66
Caustic esophagitis 54 171 24
Severe dehydration 44 227 16.24
Dehydration induced hypotension 41 233 14.96
Methemoglobinemia 27 187 12.62
QT prolongation 37 237 13.50
Electrolyte disorders 28 245 10.26
Hemolytic anemia 26 248 9.49
Myocardial injury 19 255 6.93
Depends on the medicine 5 267 1.84
Anxiety 5 269 1.82
Headaches 4 269 1.47
Lower immune response 2 240 0.83

Regarding the consequences, the respondants believed that antibiotic resistance was a major aftermath of the increased self-medication (74.4%). The worsening of COVID-19 symptoms (52.55%) was perceived as the second major consequence followed by lower immune response (45.26%) and delayed medical care (39.78%) (Table 3).

Table 3 Perception on the consequences of self-medication on COVID-19 treatment 

Consequences of self-medication Yes No % Yes
Delayed medical care 109 165 39.78
Lower immune response 124 150 45.26
Antibiotic resistance 204 70 74.45
Worsens COVID-19 symptoms 144 130 52.55

DISCUSSION

The study aimed to characterize Pharmacy faculty and student’s perception of self-medication in the Peruvian population in the context of the COVID-19 pandemic. A significant majority considered that self-medication increased significantly during the pandemic due to the general feeling of anguish towards a new disease with no available treatment. These results are consistent with other studies that identify anxiety about the new disease as the main cause of self-medication6,12,16.

In our study, respondents reported that it is the onset of symptoms associated with COVID-19 that triggers self-medication. As is well known, the symptoms of the disease are diverse17. This result is consistent with other findings in Peru12, Bangladesh9 and Togo10. However, these studies found people who reported self-medicating even without having symptoms9.

In the study, respondents identified pharmacies and drugstores as the places where medicines are most frequently obtained, and it is the pharmacy technician who prescribes the medicine to take, followed by a family member or acquaintance who has had COVID-19 and pharmacists. The adverse effects of self-medication may be unknown to the community; however, health professionals and pharmacy technicians do acquire competencies on these issues throughout their training. A study of pharmacy technicians found a high level of knowledge of adverse drug reactions to ivermectin, azithromycin and dexamethasone for the treatment of COVID-1918.

In the study, ivermectin and azithromycin were identified as the most frequently used by the population. Other studies show that hydroxychloroquine is the most frequently used drug19-21. A study in Peru regarding pre-hospital medication revealed that 85.8% of patients used antibiotics and 66.9% used ivermectin22; However, studies on the indiscriminate use of dexamethasone, enoxaparin or chlorine dioxide have not yet been reported, despite empirical evidence to the contrary.

Regarding the adverse effects and consequences of self-medication, given the nature of the drugs perceived as most commonly used, serious adverse effects are likely to occur23. Especially anticoagulants or drugs not recommended for use in the pandemic24.

It is necessary for future pharmacists to be prepared to deal with self-medication in the community, especially if it puts people's health and lives at risk by delaying medical attention or worsening COVID-19 conditions. Community pharmacists play a vital role in the provision of medicines and health education, in response to the demands of the population who seek help in pharmacies, drugstores, etc. This is corroborated in a study conducted in Zambia, analyzing this role and concluding that pharmacists were prepared to participate in the front line against the COVID-19 pandemic25.

The study concludes that Pharmacy and Biochemistry students in Lima, Peru; perceive that self-medication practices have increased in the general population during the COVID-19 pandemic. The role of pharmacists in disseminating the risks of self-medication and indiscriminate use of drugs through health education campaigns is important. National surveillance of self-medication during the COVID-19 pandemic is needed.

BIBLIOGRAPHIC REFERENCES

1. Shaghaghi A, Asadi M, Allahverdipour H. Predictors of self-medication behavior: A systematic review. Iran J Public Health [Internet]. 2014 [cited 2020 dic 16];43(2):136-46. Available from: https://ijph.tums.ac.ir/index.php/ijph/article/view/4243Links ]

2. Castel JM, Laporte J-R, Reggi V, Aguirre J, de Buschiazzo PM, Coelho HL, et al. Multicenter study on self-medication and self-prescription in six Latin American countries. Clinical Pharmacology & Therapeutics. 1997;61(4):488-93. doi: 10.1016/s0009-9236(97)90199-5 [ Links ]

3. Urrunaga-Pastor D, Benites-Zapata VA, Mezones-Holguín E. Factors associated with self-medication in users of drugstores and pharmacies in Peru: an analysis of the National Survey on User Satisfaction of Health Services, ENSUSALUD 2015. F1000Research. 2019;8:23. doi: 10.12688/f1000research.17578.2 [ Links ]

4. Ruiz ME. Risks of self-medication practices. Curr Drug Saf. 2010;5(4):315-23. doi: 10.2174/157488610792245966 [ Links ]

5. Onchonga D, Omwoyo J, Nyamamba D. Assessing the prevalence of self-medication among healthcare workers before and during the 2019 SARS-CoV-2 (COVID-19) pandemic in Kenya. Saudi Pharm J. 2020;28(10):1149-54. doi: 10.1016/j.jsps.2020.08.003 [ Links ]

6. Gianella C, Gideon J, Romero MJ. What does COVID-19 tell us about the Peruvian health system? Canadian Journal of Development Studies. 2020;42(1-2):55-67. doi: 10.1080/02255189.2020.1843009 [ Links ]

7. Wilder-Smith A, Freedman DO. Isolation, quarantine, social distancing and community containment: pivotal role for old-style public health measures in the novel coronavirus (2019-nCoV) outbreak. J Travel Med. 2020;27(2):taaa020. doi: 10.1093/jtm/taaa020 [ Links ]

8. Nasir M, Mannam M, Chowdhury ASM, Zahan T, Perveen RA. Prevalence, Pattern and Impact of Self Medication of Anti-infective Agents During COVID-19 Outbreak in Dhaka City. Global Journal of Medical Research. 2020;1-8. doi: 10.34257/GJMRBVOL20IS7PG1 [ Links ]

9. Sadio AJ, Gbeasor-Komlanvi FA, Konu RY, Bakoubayi AW, Tchankoni MK, Bitty-Anderson AM, et al. Assessment of self-medication practices in the context of the COVID-19 outbreak in Togo. BMC Public Health. 2021;21(1). doi: 10.1186/s12889-020-10145-1 [ Links ]

10. Kong JD, Tchuendom RF, Adeleye SA, David JF, Admasu FS, Bakare EA, et al. SARS-CoV-2 and self-medication in Cameroon: a mathematical model. Journal of Biological Dynamics. 2021;15(1):137-50. doi: 10.1080/17513758.2021.1883130 [ Links ]

11. Quispe-Cañari JF, Fidel-Rosales E, Manrique D, Mascaró-Zan J, Huamán-Castillón KM, Chamorro-Espinoza SE. Self-medication practices during the COVID-19 pandemic among the adult population in Peru: A cross-sectional survey. Saudi Pharmaceutical Journal. 2021;29(1):1-11. doi: 10.1016/j.jsps.2020.12.001 [ Links ]

12. Calderón CA, Soler F, Pérez-Acosta AM. El Observatorio del Comportamiento de Automedicación de la Universidad del Rosario y su rol en la pandemia de COVID-19. Revista ciencias de la salud [Internet]. 2020 [citado 16 dic 2020],18(2):1-8. Disponible en: http://www.scielo.org.co/scielo.php?script=sci_arttext&pid=S1692-72732020000200001Links ]

13. Arrebola C, García-Delgado P, Labrador-Barba E, Orera-Peña ML, Martínez-Martínez F. Percepción farmacéutica del uso de analgésicos y su práctica en dolor leve-moderado. Encuesta DOLOR-OFF. Aten Primaria. 2016;48(6):366-73. doi: 10.1016/j.aprim.2015.05.010 [ Links ]

14. Ministerio de Salud. Ley N° 26842, Ley General de Salud [Internet]. MINSA, 1993 [citado 16 dic 2020]. Disponible en: https://www.gob.pe/institucion/minsa/normas-legales/256661-26842Links ]

15. Akour A, Elayeh E, Tubeileh R, Hammad A, Ya’Acoub R, Al-Tammemi AB. Role of community pharmacists in medication management during COVID-19 lockdown. Pathogens and Global Health. 2021;115(3):168-77. doi: 10.1080/20477724.2021.1884806 [ Links ]

16. Wegbom AI, Edet CK, Raimi O, Fagbamigbe AF, Kiri VA. Self-Medication Practices and Associated Factors in the Prevention and/or Treatment of COVID-19 Virus: A Population-Based Survey in Nigeria. Front Public Health. 2021;9:606801. doi: 10.3389/fpubh.2021.606801 [ Links ]

17. Pérez-Abreu MR, Gómez-Tejeda JJ, Dieguez-Guach RA. Características clínico-epidemiológicas de la COVID-19. Revista Habanera de Ciencias Médicas [Internet]. 2020 [citado 16 dic 2020];19(2):1-15. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1729-519X2020000200005Links ]

18. Fernandez-Lozano O, Ramos-Mautino D. Nivel de conocimiento de reacciones adversas de medicamentos (ivermectina, azitromicina y dexametasona) para el tratamiento de covid-19 en técnicos de farmacia, en la Av. Canto Grande-SJL, en 2020 [Tesis]. Lima: Facultad de Medicina, Universidad María Auxiliadora; 2021 [citado 16 dic 2020]. Disponible en: http://repositorio.uma.edu.pe/handle/UMA/306Links ]

19. Gustavo-Lima W, Gatti -Cardoso B, Carolina-Simião D, Mendes-Amorim J, de Araújo-Silva C, Moreira Brito JC. Uso irracional de medicamentos e plantas medicinais contra a COVID-19 (SARS-CoV-2): Um problema emergente. Brazilian Journal of Health and Pharmacy. 2020;2(3):37-53. doi: 10.29327/226760.2.3-5 [ Links ]

20. Singh AK, Singh A, Singh R, Misra A. “Hydroxychloroquine in patients with COVID-19: A Systematic Review and meta-analysis.” Diabetes Metab Syndr Clin Res Rev. 2020;14(4):589-96. doi: 10.1016/j.dsx.2020.05.017 [ Links ]

21. Shamshirian A, Hessami A, Heydari K, Navaei RA, Ebrahimzadeh MA, Yip GW, et al. The role of hydroxychloroquine in COVID-19 treatment: a systematic review and meta-analysis. Ann Acad Med Singap [Internet]. 2020 [cited 2020 dic 16];49(10):789-800. Available from: https://pubmed.ncbi.nlm.nih.gov/33283842/Links ]

22. Zavala-Flores E, Salcedo-Matienzo J. Medicación prehospitalaria en pacientes hospitalizados por COVID-19 en un hospital público de Lima-Perú. Acta méd Perú. 2020;37(3):393-5. doi: 10.35663/amp.2020.373.1277 [ Links ]

23. Molento MB. COVID-19 and the rush for self-medication and self-dosing with ivermectin: A word of caution. One Health. 2020;10:100148. doi: 10.1016/j.onehlt.2020.100148 [ Links ]

24. Rendic SP. Metabolism and interactions of Ivermectin with human cytochrome P450 enzymes and drug transporters, possible adverse and toxic effects. Arch Toxicol. 2021;95(5):1535-46. doi: 10.1007/s00204-021-03025-z [ Links ]

25. Hangoma JM, Mudenda S, Mwenechanya MM, Kalungia AC. Community pharmacists' knowledge and preparedness to participate in the fight against Coronavirus disease 2019 (COVID-19) in Zambia. MedRxiv. 2020. doi: 10.1101/2020.09.01.20185694 [ Links ]

Funding: Self-financed study.

3Acknowledgment: Special thanks for reviewing the study to Edward Mezones Holguin.

Received: December 01, 2021; Accepted: December 28, 2021

Correspondence Agueda Muñoz del Carpio-Toia email: amunozde@ucsm.edu.pe

Conflict of interest: The authors declared no potential conflicts of interest.

Creative Commons License This is an open-access article distributed under the terms of the Creative Commons Attribution License